# The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19

> **NCT04629157** · NA · COMPLETED · sponsor: **Alder Hey Children's NHS Foundation Trust** · enrollment: 400 (actual)

## Conditions studied

- This is a Pilot Study Which Aims to Assess the Validity and Applicability of Lateral Flow Assays (LFAs) Which Can be Used as a Point of Care Test for COVID-19
- Covid19

## Interventions

- **DEVICE:** Innova Lateral Flow Device

## Key facts

- **NCT ID:** NCT04629157
- **Lead sponsor:** Alder Hey Children's NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-05
- **Primary completion:** 2021-02-01
- **Final completion:** 2021-02-01
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2024-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04629157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04629157, "The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04629157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*